Wrap Text
Acquisition Of Schirm And Withdrawal Of Cautionary Announcement
AECI LIMITED
Incorporated in the Republic of South Africa
(Registration number: 1924/002590/06)
Share code: AFE ISIN: ZAE000000220
(“AECI” or “the Company” or “the Group”)
ACQUISITION OF SCHIRM AND WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT
1. Introduction
Shareholders are advised that AECI and its wholly-owned subsidiary, AECI Mauritius Limited
(“AECI Mauritius”), has reached agreement with Imperial Chemical Logistics GmbH (“ICL”),
a wholly-owned subsidiary of Imperial Holdings Limited, and Schirm GmbH, a wholly-owned
subsidiary of ICL, in terms of which (i) AECI Mauritius will acquire 100% of the share capital
in Schirm GmbH and shareholder loan claims; and (ii) Schirm GmbH will acquire (A) the
contract manufacturing service business of ICL (“Wolfenbüttel Business”); and (B) a
property in Wolfenbüttel, Germany (“Wolfenbüttel Property”), (together, “Schirm”) (“the
Transaction”). The purchase consideration is €110,5 million (R1 808,2 million(1)) and is
payable in cash (“Purchase Consideration”). The Transaction is subject to the conditions
precedent set out in paragraph 4 below.
Schirm manufactures agrochemicals and fine chemicals. It has four sites in Germany
(Schönebeck, Wolfenbüttel, Lübeck and Baar-Ebenhausen) and one in Ennis, Texas, in the
USA.
In terms of the Transaction, ICL will retain the customer warehousing, transportation and
distribution services on the sites on which Schirm operates. For a period of one year from
the closing date of the Transaction, Schirm GmbH retains an option to acquire four
warehouses at the Schirm plant in Schönebeck from ICL for a maximum purchase
consideration of €9,0 million (R147,3 million(1)). Schirm GmbH has entered into a separate
25-year lease agreement with ICL for warehouse and factory space to meet its own
operational and raw material storage requirements, in terms of which AECI will make a
pre-payment of €3,5 million (R57,3 million(1)).
(1) calculated at the ZAR/EUR rate of R16,36 as at 7 November 2017.
2. Overview of Schirm
Schirm is an established contract chemical manufacturer which provides an integrated
service across the entire value chain of synthesis, formulation and packaging of
agrochemicals and fine chemicals. Agrochemical products include herbicides, fungicides
and insecticides while the fine chemicals portfolio comprises raw materials for the biocides,
personal and home care, adhesives and rubber industries. Schirm is the leading provider
of formulation services for agrochemicals in Europe and its services include:
- Synthesis: raw materials from suppliers or customers are converted to chemical
products and either sold to customers or utilised by Schirm in formulation processes;
- Formulation: Schirm uses products from its own synthesis process and/or products
from customers and sells formulations in bulk to those customers; and
- Packaging and labelling of liquid and solid chemical products in all packaging sizes.
The sale of agrochemicals accounts for approximately 80% of Schirm’s revenue, with fine
chemicals contributing the balance. Approximately 80% of revenue is generated in Europe,
primarily in Germany, and the rest is generated in the USA.
Schirm is a supplier to leading global crop protection chemical producers such as Bayer,
BASF, DuPont, Syngenta, Sumitomo Chemical and Lanxess. It has relationships averaging
over 30 years with its 10 largest customers.
According to global strategy consulting firm Roland Berger, Schirm's addressable synthesis
market was estimated to have a global value of €8,1 billion in 2016 and is expected to grow
by c.3,7% p.a. to 2020, driven mainly by underlying market growth and a positive price
outlook for contract manufacturing services.
In the formulation and packaging of agrochemicals, the addressable global market size was
estimated by Roland Berger at €3,4 billion in 2016 and is expected to grow at c.3,4% p.a.
to 2020, driven mainly by underlying market growth and upward price trends.
Over the last two financial years, Schirm invested approximately €25 million (R370,6
million(1)) in capital expenditure in terms of contractual arrangements with strategic
customers and on installing a state-of the-art synthesis plant at its Schönebeck site. Spare
capacity remaining from the upgrade will be filled in the coming years. These investments
have provided the additional capacity necessary to achieve significant growth in Schirm’s
synthesis operations, with the resultant financial benefits expected from the financial year
ending 30 June 2018. The benefits of this capital expenditure are not reflected in historical
financial information.
(1) calculated at the average ZAR/EUR rate of R14,82 for the year ended 30 June 2017.
3. Rationale for the Transaction
In addition to domestic growth, AECI’s focus is also on expansion outside South Africa in
its chosen strategic areas of Mining Solutions, Water & Process, Plant & Animal Health,
Food & Beverage, and Chemicals.
AECI already has well-established businesses in Africa, South East Asia, the USA and
Australia. The Transaction is in line with the Company’s international expansion strategy.
Schirm presents a strong investment case for AECI:
- it is a market leader in the provision of formulation services for agrochemicals in
Europe;
- it has long-standing customer relationships with its blue-chip customer base;
- it has invested substantially in capital expenditure over the past two years and it is
expected that this investment will enable significant revenue growth as well as cost
efficiencies;
- there are potential synergies associated with the extension of Schirm’s manufacturing
expertise to AECI as well as expansion and supply chain opportunities for the Group’s
existing Plant & Animal Health pillar;
- there are opportunities for AECI to replace some of the raw materials it currently
imports from third parties;
- enhanced geographic and product diversity for AECI’s wider chemicals portfolio;
- there are also potential synergistic benefits associated with differing seasonal demand
cycles in the northern and southern hemispheres; and
- it provides currency diversification for AECI.
2
Schirm will operate as a stand-alone entity, in AECI’s Plant & Animal Health pillar.
4. Conditions precedent
The closing of the Transaction is subject to the fulfilment or waiver (if possible) of the
following conditions precedent:
- approval by the German Federal Cartel Office, Germany’s national competition
regulator;
- the German Federal Ministry of Economics and Energy issuing a clearance certificate
for the Transaction;
- approval by the Financial Surveillance department of the South African Reserve Bank;
- registration of a first ranking priority notice in respect of the transfer of the ownership
of the Wolfenbüttel Property in favour of Schirm GmbH; and
- the municipal authority waiving its statutory rights of pre-emption (or issuing a
certificate of non-applicability) relating to the Wolfenbüttel Property.
Warranties and indemnities typical of a transaction of this nature have been provided for.
The closing date of the Transaction will be the last business day of the month in which the
last closing condition is fulfilled or, as the case may be, waived (if so permitted). However,
if there are less than eight business days between the date of such fulfillment or waiver
and the end of the then current month, closing shall take place on the last business day of
the next month or any other business day mutually agreed upon in writing.
5. Purchase consideration
The Purchase Consideration for the Transaction has been structured as a “locked-box” with
an effective date of 30 June 2017, subject to a separate trade working capital adjustment
mechanism on the closing date of the Transaction.
AECI will fund the Transaction utilising a financing facility provided by The Standard Bank
of South Africa Limited.
6. Financial information
For the year ended 30 June 2017, the net asset value of Schirm was €14,4 million (R215,0
million(2)), inclusive of shareholder loan claims to ICL of €55,9 million (R834,5 million(2))
and it delivered revenue of €115,6 million (R1 713,7 million(2)), EBITDA of €13,8 million
(R204,6 million(2)), EBIT of €9,7 million (R143,8 million(2)) and profits after tax of €5,2
(R77,1 million(2)) million attributable to the net assets. These audited figures were prepared
in conformity with International Financial Reporting Standards.
(2) The spot ZAR/EUR exchange of R14,93 has been applied to convert net assets as at 30 June 2017 and the
average exchange rate of R14,82 for the year ended 30 June 2017 has been applied to convert profit and loss
items.
7. Categorisation of the Transaction
The Transaction is classified as a Category 2 transaction for AECI in terms of the Listings
Requirements of the JSE Limited (“Listings Requirements”).
Following the implementation of the Transaction, Schirm GmbH and Schirm GmbH’s wholly-
owned subsidiary Schirm U.S.A., Inc., will become wholly-owned subsidiaries of AECI. The
Company confirms that Schirm’s constitutional documents enable AECI to continue to
comply with its obligations in terms of the Listings Requirements.
8. Withdrawal of cautionary announcement
Shareholders are referred to the further cautionary announcement dated 30 October 2017.
As the full details of the Transaction have now been released, shareholders no longer need
to exercise caution when dealing in their AECI securities.
Woodmead, Sandton
8 November 2017
Investment Bank, Corporate Advisor and Transaction Sponsor
The Standard Bank of South Africa Limited
Legal Advisors to AECI
Webber Wentzel and Linklaters LLP
Date: 08/11/2017 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.